Social Media Ideas for Innovation Rx

<![CDATA[The Ron Lanton Report: From Innovation to Infrastructure]]>

Innovation alone is no longer enough in biopharma

In biopharma, the next edge may come from the systems that turn discovery into scale.

Innovation Engineering: How Firms Can Think Bigger and Ask Better Questions

Most firms are aiming their newest tools at the work they already do — pouring their most powerful technology into running the same tasks a little faster. But when everyone automat...

<![CDATA[China Pharma Trends: Premium Pricing and Priority Access for True Innovations]]>

<![CDATA[Rethinking Pharma's Go-to-Market Formula]]>

<![CDATA[Evolving Beyond Launch Postmortems to Real-Time Optimization]]>

The hidden innovation system behind drug repurposing 

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of research starts. The post The hidden innovation system be...

Innovation Fatigue in Healthcare Is Real, Here’s How to Avoid It

The following is a guest article by Melissa Powell, President & Chief Operating Officer at The Allure Group Healthcare has never lacked innovation. The industry is currently ex...

The rhetorical mask of innovation

How a single word lets us claim progress before we proveВ it1970s Reliant Robin | Image source: https://www.adrianflux.co.uk/cult-classics/reliant-robin/What is innovation? We hear...

Success Stories: AI-Powered Pharmaceutical Innovation

As AI (artificial intelligence), advanced manufacturing, and biotechnology continue to evolve, universities and industry leaders are forming major partnerships to accelerate the fu...

<![CDATA[“AI as Reinvention”: Transforming the Business of Medicine]]>

<![CDATA[Pharmaceutical Executive Daily: AI as Reinvention]]>

<![CDATA[TrumpRx Expands to Offer Generic Medications]]>

Life Sciences: Where Innovation Meets Risk

The life sciences industry, long known for its innovation and complexity, continues to evolve at a remarkable pace. From AI-powered diagnostics to wearable monitors and at-home gen...

Big Pharma Is Buying Innovation Again. Have They Given Up on Their Own R&D?

Big Pharma Is Buying Innovation Again. Have They Given Up on Their Own R&D? Anonymous (not verified) Wed, 06/24/2026 - 03:01 pharmagather item url Big...

<![CDATA[Nuvation Bio’s Global Strategy]]>

<![CDATA[What Do You See as The Next Phase of Obesity Innovation?]]>

Biopharmaceutical Innovation: The Patent Imperative

America’s $150 billion per year private sector investment in biopharmaceutical research and development (R&D) does more than offer comfort. Increasingly, American innovators ar...

How Foreign Reference Pricing Embeds Valuations And Risks Undermining Global Innovation

That is the title of my new Health Affairs Forefront piece out today with Lou Garrison and Richard Xie. An excerpt from the article is below: United States policy makers increasing...

<![CDATA[Nuvation Bio’s Approach to Building a Compelling Narrative]]>

Readers Write: How Healthcare Leaders Can Balance Innovation With Governance Demands

How Healthcare Leaders Can Balance Innovation With Governance DemandsBy Chris ...

<![CDATA[Driving Progress]]>

<![CDATA[Abu Dhabi Advances an Integrated Model for Global Life Sciences Innovation ]]>

<![CDATA[Johns Hopkins Technology Ventures Expands the Path from Discovery to Commercialization]]>